Need professional-grade analysis? Visit stockanalysis.com
$14.43B
61.65
132
0.47%
Pro Medicus Ltd (PME) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at AUD148.74, down 0.09% from the previous close.
Over the past year, PME has traded between a low of AUD108.15 and a high of AUD330.14. The stock has lost 27.5% over this period. It is currently 54.9% below its 52-week high.
Pro Medicus Ltd has a market capitalization of $14.43B, with a price-to-earnings ratio of 61.65 and a dividend yield of 0.47%.
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease, a mobile application that provides users access to medical imaging results; and Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
Side-by-side comparison against top Healthcare peers.